Piceatannol Exerts Anti-Obesity Effects in C57BL/6 Mice Through Modulating Adipogenic Proteins and Gut Microbiota

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2016 Oct 30

PMID 27792146

Citations 41

Authors

Yen-Chen Tung

Yu-Hsuan Lin

Hong-Jhang Chen

Shen-Chieh Chou

An-Chin Cheng

Nagabhushanam Kalyanam

Chi-Tang Ho

Min-Hsiung Pan

Affiliations

Soon will be listed here.

Abstract

Obesity is a global health concern. Piceatannol (Pic), an analog of resveratrol (Res), has many reported biological activities. In this study, we investigated the anti-obesity effect of Pic in a high-fat diet (HFD)-induced obese animal model. The results showed that Pic significantly reduced mouse body weight in a dose-dependent manner without affecting food intake. Serum total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL) levels, and blood glucose (GLU) were significantly lowered in Pic-treated groups. Pic significantly decreased the weight of liver, spleen, perigonadal and retroperitoneal fat compared with the HFD group. Pic significantly reduced the adipocyte cell size of perigonadal fat and decreased the weight of liver. Pic-treated mice showed higher phosphorylated adenosine 5'-monophosphate-activated protein kinase (pAMPK) and phosphorylated acetyl-CoA carboxylase (pACC) protein levels and decreased protein levels of CCAAT/enhancer-binding protein C/EBPα, peroxisome proliferator-activated receptor PPARγ and fatty acid synthase (FAS), resulting in decreased lipid accumulation in adipocytes and the liver. Pic altered the composition of the gut microbiota by increasing Firmicutes and and decreasing Bacteroidetes compared with the HFD group. Collectively, these results suggest that Pic may be a candidate for obesity treatment.

Citing Articles

Diverse effects of a Cyperus rotundus extract on glucose uptake in myotubes and adipocytes and its suppression on adipocyte maturation.

Pichetkun V, Khine H, Srifa S, Nukulkit S, Nuengchamnong N, Hansapaiboon S Sci Rep. 2024; 14(1):9018.

PMID: 38641685 PMC: 11031566. DOI: 10.1038/s41598-024-59357-0.

Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases.

Ferreira C, Vieira P, Sa H, Malva J, Castelo-Branco M, Reis F Front Immunol. 2024; 15:1360065.

PMID: 38558823 PMC: 10978763. DOI: 10.3389/fimmu.2024.1360065.

The Mechanism of the Anti-Obesity Effects of a Standardized Extract in 3T3-L1 Preadipocytes and High-Fat Diet-Induced Obese C57BL/6J Mice.

Lim J, Im J, Han X, Men X, Oh G, Fu X Nutrients. 2024; 16(6).

PMID: 38542756 PMC: 10975248. DOI: 10.3390/nu16060846.

Regulation and targeting of SREBP-1 in hepatocellular carcinoma.

Su F, Koeberle A Cancer Metastasis Rev. 2023; 43(2):673-708.

PMID: 38036934 PMC: 11156753. DOI: 10.1007/s10555-023-10156-5.

Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies.

Corrie L, Awasthi A, Kaur J, Vishwas S, Gulati M, Kaur I Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259345 PMC: 9967581. DOI: 10.3390/ph16020197.

References

Winder W, Hardie D . AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol. 1999; 277(1):E1-10. DOI: 10.1152/ajpendo.1999.277.1.E1. View

Kopelman P . Obesity as a medical problem. Nature. 2000; 404(6778):635-43. DOI: 10.1038/35007508. View

Kershaw E, Flier J . Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004; 89(6):2548-56. DOI: 10.1210/jc.2004-0395. View

Murias M, Jager W, Handler N, Erker T, Horvath Z, Szekeres T . Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem Pharmacol. 2005; 69(6):903-12. DOI: 10.1016/j.bcp.2004.12.001. View

Baur J, Sinclair D . Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006; 5(6):493-506. DOI: 10.1038/nrd2060. View

Ley R, Turnbaugh P, Klein S, Gordon J . Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444(7122):1022-3. DOI: 10.1038/4441022a. View

Backhed F, Manchester J, Semenkovich C, Gordon J . Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007; 104(3):979-84. PMC: 1764762. DOI: 10.1073/pnas.0605374104. View

Reagan-Shaw S, Nihal M, Ahmad N . Dose translation from animal to human studies revisited. FASEB J. 2007; 22(3):659-61. DOI: 10.1096/fj.07-9574LSF. View

Cani P, Delzenne N . The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009; 15(13):1546-58. DOI: 10.2174/138161209788168164. View

10.

Schreurs M, Kuipers F, van der Leij F . Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Obes Rev. 2009; 11(5):380-8. DOI: 10.1111/j.1467-789X.2009.00642.x. View

11.

Caporaso J, Lauber C, Walters W, Berg-Lyons D, Lozupone C, Turnbaugh P . Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2010; 108 Suppl 1:4516-22. PMC: 3063599. DOI: 10.1073/pnas.1000080107. View

12.

Moffat C, Harper M . Metabolic functions of AMPK: aspects of structure and of natural mutations in the regulatory gamma subunits. IUBMB Life. 2010; 62(10):739-45. DOI: 10.1002/iub.387. View

13.

Piotrowska H, Kucinska M, Murias M . Biological activity of piceatannol: leaving the shadow of resveratrol. Mutat Res. 2011; 750(1):60-82. DOI: 10.1016/j.mrrev.2011.11.001. View

14.

Kwon J, Seo S, Heo Y, Yue S, Cheng J, Lee K . Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation. J Biol Chem. 2012; 287(14):11566-78. PMC: 3322826. DOI: 10.1074/jbc.M111.259721. View

15.

Kanneganti T, Dixit V . Immunological complications of obesity. Nat Immunol. 2012; 13(8):707-12. DOI: 10.1038/ni.2343. View

16.

Alberdi G, Rodriguez V, Teresa Macarulla M, Miranda J, Churruca I, Portillo M . Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet. Nutrition. 2013; 29(3):562-7. DOI: 10.1016/j.nut.2012.09.011. View

17.

Zhang T, Sawada K, Yamamoto N, Ashida H . 4-Hydroxyderricin and xanthoangelol from Ashitaba (Angelica keiskei) suppress differentiation of preadiopocytes to adipocytes via AMPK and MAPK pathways. Mol Nutr Food Res. 2013; 57(10):1729-40. DOI: 10.1002/mnfr.201300020. View

18.

Bluher M . Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2013; 27(2):163-77. DOI: 10.1016/j.beem.2013.02.005. View

19.

Corey K, Kaplan L . Obesity and liver disease: the epidemic of the twenty-first century. Clin Liver Dis. 2013; 18(1):1-18. DOI: 10.1016/j.cld.2013.09.019. View

20.

Setoguchi Y, Oritani Y, Ito R, Inagaki H, Maruki-Uchida H, Ichiyanagi T . Absorption and metabolism of piceatannol in rats. J Agric Food Chem. 2014; 62(12):2541-8. DOI: 10.1021/jf404694y. View